Aprea Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Aprea Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • Aprea Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $49.4M, a 13.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $49.4M +$5.81M +13.3% Dec 31, 2023 10-K 2024-03-26
Q4 2022 $43.6M +$1.51M +3.6% Dec 31, 2022 10-K 2024-03-26
Q4 2021 $42.1M +$8.57M +25.6% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $33.5M +$13.9M +70.5% Dec 31, 2020 10-K 2022-03-15
Q4 2019 $19.7M +$7.01M +55.4% Dec 31, 2019 10-K 2021-03-16
Q4 2018 $12.7M Dec 31, 2018 10-K 2020-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.